The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Cephalon Inc. has agreed to pay $425 million to end a federal investigation into its marketing practices concerning sleep and pain drugs. It will also have to plead guilty to a misdemeanor charge of violating federal prescription drug laws. Cephalon was sued by the Pennsylvania Turnpike Commission for attempting to delay generic drug competition.

For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.

Comments are closed.

Of Interest